Adamantane
CAS No. 281-23-2
Adamantane( —— )
Catalog No. M20336 CAS No. 281-23-2
The adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 35 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAdamantane
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
-
DescriptionThe adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number281-23-2
-
Formula Weight136.23
-
Molecular FormulaC10H16
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (14.68 mM)
-
SMILESC1C2CC3CC1CC(C2)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kuca K Windisch M Soukup O et al. Adamantane a?? A Lead Structure for Drugs in Clinical Practice[J]. Current Medicinal Chemistry 2016 23(29):-.
molnova catalog
related products
-
Toyocamycin
Toyocamycin is an adenosine analog produced by Actinomycete, acts as an XBP1 inhibitor, inhibits IRE1α-induced ATP-dependent XBP1 mRNA cleavage (IC50: 80 nM).
-
Tilorone dihydrochlo...
Tilorone dihydrochloride is the first recognized synthetic, small molecular weight compound that is an orally active interferon inducer, used as an antiviral drug.
-
Vixarelimab
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody with affinity for the beta chain of the OSM receptor, inhibiting IL-31 and OSM signaling.
Cart
sales@molnova.com